Management of Admitted Patients with Hypertension and Tachycardia

Initial Assessment and Management

The European Society of Cardiology recommends initiating intravenous labetalol or oral beta-blocker therapy immediately in admitted patients with hypertension and tachycardia, while investigating the underlying cause, as beta-blockers address both elevated blood pressure and heart rate, reducing cardiovascular risk 1, 2, 3
Rapid assessment for acute end-organ damage, including acute coronary syndrome, acute heart failure, stroke symptoms, or acute kidney injury, is crucial in patients with hypertension and tachycardia 4, 5
Identifying precipitating factors such as recent cocaine or methamphetamine use, pheochromocytoma, thyroid storm, pain, or anxiety is essential for appropriate management 4, 6

The American Heart Association suggests that intravenous labetalol is the preferred agent for severe hypertension with tachycardia, providing both alpha and beta blockade, with a starting dose of 5 mg/hr and titration by 2.5 mg/hr every 15 minutes until blood pressure and heart rate are controlled 1, 2, 4
Oral beta-blocker therapy, such as metoprolol succinate 50 mg daily or carvedilol 12.5 mg twice daily, can be started immediately for moderate hypertension with tachycardia, controlling blood pressure, reducing heart rate, and suppressing ventricular ectopy if present 3, 5

In patients with cocaine or methamphetamine intoxication, the American College of Cardiology recommends avoiding beta-blockers and using benzodiazepines, such as lorazepam 2-4 mg IV, alone or combined with nitroglycerin, as first-line treatment 6
For acute coronary syndrome, the American Heart Association suggests using intravenous nitroglycerin plus intravenous esmolol or oral beta-blocker, and adding ACE inhibitor once hemodynamically stable 5

The European Society of Cardiology recommends aiming for systolic BP 120-129 mmHg if well tolerated, as optimal blood pressure control reduces arrhythmia frequency, and avoiding diastolic BP <60 mmHg, especially in older patients or those with coronary disease 3, 5
Continuous cardiac monitoring for heart rate and rhythm, and blood pressure monitoring every 5-15 minutes during titration, then hourly once stable, are crucial during the acute phase 1, 2, 4